These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19131627)

  • 1. The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription.
    Wright CW; Duckett CS
    Science; 2009 Jan; 323(5911):251-5. PubMed ID: 19131627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
    Buchan SL; Al-Shamkhani A
    PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
    Wright CW; Rumble JM; Duckett CS
    J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines.
    Vogel CF; Sciullo E; Matsumura F
    Biochem Biophys Res Commun; 2007 Nov; 363(3):722-6. PubMed ID: 17900530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
    Horie R; Watanabe M; Ishida T; Koiwa T; Aizawa S; Itoh K; Higashihara M; Kadin ME; Watanabe T
    Cancer Cell; 2004 Apr; 5(4):353-64. PubMed ID: 15093542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.
    Vogel CF; Sciullo E; Li W; Wong P; Lazennec G; Matsumura F
    Mol Endocrinol; 2007 Dec; 21(12):2941-55. PubMed ID: 17823304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity.
    Gardella KA; Muro I; Fang G; Sarkar K; Mendez O; Wright CW
    Oncotarget; 2016 Mar; 7(10):10710-22. PubMed ID: 26909609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
    Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
    J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin.
    Rüegg J; Swedenborg E; Wahlström D; Escande A; Balaguer P; Pettersson K; Pongratz I
    Mol Endocrinol; 2008 Feb; 22(2):304-16. PubMed ID: 17991765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AhR and Arnt differentially regulate NF-κB signaling and chemokine responses in human bronchial epithelial cells.
    Øvrevik J; Låg M; Lecureur V; Gilot D; Lagadic-Gossmann D; Refsnes M; Schwarze PE; Skuland T; Becher R; Holme JA
    Cell Commun Signal; 2014 Jul; 12():48. PubMed ID: 25201625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
    Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
    Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
    Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
    Boddicker RL; Kip NS; Xing X; Zeng Y; Yang ZZ; Lee JH; Almada LL; Elsawa SF; Knudson RA; Law ME; Ketterling RP; Cunningham JM; Wu Y; Maurer MJ; O'Byrne MM; Cerhan JR; Slager SL; Link BK; Porcher JC; Grote DM; Jelinek DF; Dogan A; Ansell SM; Fernandez-Zapico ME; Feldman AL
    Blood; 2015 May; 125(20):3118-27. PubMed ID: 25833963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma.
    Eluard B; Nuan-Aliman S; Faumont N; Collares D; Bordereaux D; Montagne A; Martins I; Cagnard N; Caly M; Taoui O; Lordello L; Lehmann-Che J; Tesson B; Martinez-Climent JA; Copie-Bergman C; Haioun C; Tilly H; Bonsang B; Vincent-Salomon A; Jais JP; Jardin F; Leroy K; Maiuri MC; Kroemer G; Molina TJ; Feuillard J; Baud V
    Blood; 2022 Jan; 139(3):384-398. PubMed ID: 34232979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
    Nishikori M; Ohno H; Haga H; Uchiyama T
    Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
    Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
    Front Immunol; 2019; 10():997. PubMed ID: 31134075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.
    Suzuki O; Hirsch B; Abe M; Dürkop H; Stein H
    Lab Invest; 2012 Feb; 92(2):191-9. PubMed ID: 21986812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB.
    Leidner J; Voogdt C; Niedenthal R; Möller P; Marienfeld U; Marienfeld RB
    J Cell Biochem; 2014 Aug; 115(8):1430-40. PubMed ID: 24616021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.